Therapeutic agent for ageing macular degeneration

Details Therapeutic agent for ageing macular degeneration Therapeutic agent for ageing macular degeneration

A - Human Necessities

61

K

A61K 31/57 (2006.01) A61K 9/06 (2006.01) A61K 9/08 (2006.01) A61P 27/00 (2006.01) C07J 7/00 (2006.01)

Patent

CA 2537874

A drug exhibiting an excellent therapeutic efficacy for ageing macular degeneration. In particular, a therapeutic agent for ageing macular degeneration characterized in that a progesterone derivative of the general formula: (1) (wherein R1 is a C1-C23 alkyl) is contained as an active ingredient.

La présente invention se rapporte à un médicament qui présente une excellente efficacité thérapeutique contre la dégénérescence maculaire liée à l'âge. L'invention a trait en particulier à un agent thérapeutique contre la dégénérescence maculaire liée à l'âge qui contient, en tant qu'ingrédient actif, un dérivé de la progestérone représenté par la formule générale (I), dans laquelle R?1¿ représente un alkyle C¿1-?C¿23?.

Affiliated with

Also associated with

Rating

Therapeutic agent for ageing macular degeneration does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Therapeutic agent for ageing macular degeneration, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic agent for ageing macular degeneration will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1367209